首页> 外文期刊>Biochemical and Biophysical Research Communications >Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells
【24h】

Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells

机译:鉴定一种主要在人癌组织和细胞中表达的新型有机阴离子转运多肽1B3 mRNA同工型

获取原文
获取原文并翻译 | 示例
           

摘要

Organic anion transporting polypeptide 1B3 (OATP1B3) is a hepatocyte plasma membrane protein that transports various endogenous and xenobiotic compounds. Although it is exclusively expressed in the human liver under normal conditions, OATP1B3 can be also expressed in various human cancer tissues that have been associated with prognosis and clinical outcomes. However, despite the potential significance of the latter finding, no experimental evidence addressing the molecular entity of cancer-associated OATP1B3 has been provided to date. In this paper, we report the identification of a new OATP1B3 mRNA isoform expressed in human colon and lung cancer tissues, which we named cancer-type OATP1B3 (Ct-OATP1B3). Our results also make known a previously unidentified transcription start site and an alternative promoter region, localized at intron 2, from which Ct-OATP1B3 mRNA is generated. Isoform specific mRNA quantification showed that the Ct-OATP1B3 mRNA level was strikingly higher than that of Lt-OATP1B3 mRNA in human cancer tissues. In addition, the results showed that the translation occurred at three out of four open reading frames. To summarize, our results clearly demonstrate that the newly-identified Ct-OATP1B3 (but not Lt-OATP1B3) is the primary mRNA isoform, at least in the human cancerous samples we have examined. In line with the possibility that its translation products play important biological roles in cancer cells, we strongly believe that the existence of Ct-OATP1B3 should be taken into account during future studies of OATP1B3 associated with cancer prognosis and clinical outcomes.
机译:有机阴离子转运多肽1B3(OATP1B3)是肝细胞质膜蛋白,可转运各种内源性和异源性化合物。尽管OATP1B3在正常情况下仅在人肝中表达,但它也可以在与预后和临床结果相关的各种人类癌症组织中表达。然而,尽管后一个发现具有潜在的意义,但迄今为止,尚未提供针对癌症相关OATP1B3分子实体的实验证据。在本文中,我们报告了在人结肠和肺癌组织中表达的一种新的OATP1B3 mRNA同工型的鉴定,我们将其命名为癌症型OATP1B3(Ct-OATP1B3)。我们的结果还使之前未知的转录起始位点和位于内含子2的替代启动子区域已知,从中生成Ct-OATP1B3 mRNA。亚型特异性mRNA定量显示,在人类癌症组织中,Ct-OATP1B3 mRNA水平显着高于Lt-OATP1B3 mRNA水平。另外,结果表明翻译发生在四个开放阅读框中的三个。总而言之,我们的结果清楚地表明,至少在我们检查过的人类癌症样本中,新近鉴定出的Ct-OATP1B3(而不是Lt-OATP1B3)是主要的mRNA亚型。鉴于其翻译产物在癌细胞中起重要生物学作用的可能性,我们坚信Ct-OATP1B3的存在应在与癌症预后和临床结果相关的OATP1B3的未来研究中予以考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号